StonvexLoading…
StonvexStonvexStonvexCore line items from ALKS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $392.91M | $1.48B | $1.09B | $697.17M |
Operating Income | $-48.28M | $253.96M | $195.85M | $106.77M |
Net Income | $-66.48M | $241.66M | $192.32M | $87.10M |
EPS (Diluted) | $-0.40 | $1.43 | $1.14 | $0.65 |
Total Assets | $4.26B | $2.49B | $2.33B | $2.25B |
Total Liabilities | $2.51B | $667.70M | $596.08M | $628.23M |
Cash & Equivalents | $351.55M | $388.57M | $616.45M | $521.20M |
Free Cash Flow OCF − CapEx | $-169.83M | $480.33M | $310.25M | $225.89M |
Shares Outstanding | 166.46M | 165.61M | 165.10M | 165.05M |